tiprankstipranks
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market

Appili Therapeutics Inc Class A (APLIF) Income Statement

Compare
81 Followers

Appili Therapeutics Inc Class A Income Statement

Last quarter (Q2 2024), Appili Therapeutics Inc Class A's total revenue was C$4.69K, a decrease of -98.61% from the same quarter last year. In Q2, Appili Therapeutics Inc Class A's net income was C$-743.49K. See Appili Therapeutics Inc Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
C$ 827.41KC$ 334.18KC$ 1.39MC$ 0.00C$ 199.11K
Gross Profit
C$ 827.41KC$ 327.91KC$ 1.39MC$ -14.84KC$ 199.11K
Operating Expenses
C$ 8.84MC$ 8.11MC$ 24.95MC$ 16.28MC$ 5.60M
Depreciation and Amortization
C$ 13.66KC$ 6.27KC$ 12.64KC$ 14.84KC$ 17.75K
EBITDA
C$ -2.10MC$ -8.19MC$ -24.31MC$ -14.87MC$ -5.63M
Operating Income
C$ -8.05MC$ -7.91MC$ -24.68MC$ -16.30MC$ -6.13M
Other Income/Expenses
C$ 4.34MC$ -1.29MC$ -401.36KC$ 1.34MC$ 28.06K
Pretax Income
C$ -3.71MC$ -9.21MC$ -25.08MC$ -14.95MC$ -5.42M
Net Income
C$ -3.78MC$ -9.24MC$ -25.12MC$ -14.33MC$ -5.42M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.03C$ -0.08C$ -0.38C$ -0.24C$ -0.16
Diluted EPS
C$ -0.03C$ -0.08C$ -0.38C$ -0.24C$ -0.16
Weighted Average Shares Outstanding
121.27M 113.73M 66.73M 59.18M 34.33M
Weighted Average Shares Outstanding (Diluted)
121.27M 113.73M 66.73M 59.18M 34.33M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis